Princeton, NJ-based Derma Sciences has announced FDA 510(k) approval of its MEDIHONEY Hydrogel Wound and Burn Dressing. This newest entry in the company’s MEDIHONEY line of dressings is indicated for treatment of first and second degree burns.
Derma Sciences plans to launch both prescription and over the counter varieties of the hydrogel next year, and has begun seeking CE Mark approval for a European launch.
From the product page:
MEDIHONEY® dressings, a unique line of dressings containing Active Leptospermum Honey from New Zealand, possess unique qualities that make them ideal for the management of chronic and acute wounds and burns. A strong and growing evidence base – including several large scale randomized controlled studies – have shown that MEDIHONEY® dressings are effective on hard-to-heal wounds and burns, in addition to helping to debride wounds and keeping wound beds clean of necrotic tissue.
Because they contain a very high percentage of Leptospermum honey, MEDIHONEY® dressings are able to work in the presence of wound fluid, blood, and tissue, thus promoting an optimal healing environment.
Product page: About MEDIHONEY®…